RedHill Biopharma Ltd. RDHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.10M | -5.12M | -4.13M | -6.72M | -9.31M |
| Total Depreciation and Amortization | 141.00K | 154.50K | 168.00K | 268.50K | 369.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.16M | 2.23M | 1.30M | 2.55M | 3.37M |
| Change in Net Operating Assets | -1.07M | -844.00K | -622.00K | -542.50K | -463.00K |
| Cash from Operations | -3.86M | -3.58M | -3.29M | -4.45M | -6.04M |
| Capital Expenditure | -14.00K | -9.00K | -4.00K | -8.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 386.00K | 193.00K | -- | -- | -- |
| Cash from Investing | 372.00K | 184.00K | -4.00K | -8.00K | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -81.00K | -135.00K | -189.00K | -300.00K | -411.00K |
| Issuance of Common Stock | 5.46M | 4.45M | 3.45M | 3.45M | 3.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -104.50K | 265.00K |
| Cash from Financing | 5.38M | 4.32M | 3.26M | 3.04M | 3.30M |
| Foreign Exchange rate Adjustments | -1.00K | 4.00K | 9.00K | 16.50K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -699.00K | -1.21M | -1.73M | -1.73M | -1.73M |
| Net Change in Cash | 1.19M | -281.50K | -1.75M | -3.12M | -4.45M |